Global Chemotherapy Chairs Market – Insights
Chemotherapy chairs are used for multiple purposes such as cancer treatment, autoimmune disease treatment during the infusion process of drugs. There are different type of chairs for patients such as adult chairs, pediatric chairs, bariatric chairs (for obese cancer patients). Increasing donations from the Thunder Bay Regional Health Services Foundation is expected to aid growth of global chemotherapy chairs market. For instance, in November 2013, Lake of the Woods Regional Hospital received an amount of US$ 3,785 to purchase two treatment chairs for the hospital’s chemotherapy clinic, which are designed for patients weighing over 300 pounds. The money is a grant from the Thunder Bay Regional Health Services Foundation, which will allow the hospital to order the special chemotherapy chairs.
The global chemotherapy chairs market size is estimated to be valued at US$ 503.5 million in 2018, and is expected to witness a CAGR of 5.9% over the forecast period (2019 – 2026).
Global Chemotherapy Chairs Market Share (%) Analysis, By Chair Type, 2018 & 2026
Source: Coherent Market Insights Analysis (2019)
Increasing Specialty Centers for Cancer Care is expected to Drive Growth of the Global Chemotherapy Chairs Market
The global chemotherapy chair market size is expected to witness significant growth, owing to increasing number of new cancer care centers where chemotherapy or infusion chairs are frequently used. For instance, in September 2018, Tennessee Oncology, New York Cancer & Blood Specialists, and West Cancer Center in partnership announced the launch of OneOncology a community-based cancer care center across the U.S. It is patient-centric, physician-driven, and technology-powered cancer center with a mission to improve the lives of everyone living with cancer. Furthermore, in June 2019, Arizona Blood & Cancer Specialists announced that they will open six new clinics serving patients in Tucson, Green Valley, Nogales and Safford. Together, OneOncology and Arizona Blood & Cancer Specialists will build multidisciplinary, comprehensive cancer centers to provide an exceptional, personalized experience across the continuum of care from prevention and diagnosis, to clinical trials and treatment, through survivorship, palliative, and supportive care.
Moreover, chemotherapy is also used for treatment of blood disorder, plethora of autoimmune diseases and etc. Therefore, the global chemotherapy chairs market is also expected to increase, owing to increasing prevalence autoimmune diseases worldwide. According to the American Autoimmune Related Diseases Association (AARDA) report of 2017, autoimmune diseases affect 5% to 10% of the global population, particularly women, who are two to ten times more likely to suffer from an AD than men. Some of the autoimmune diseases are within the top 10 leading causes of death among women aged 65 years and above.
There are few hospitals already taking pace in starting new cancer units with high investments on their set up which includes chemotherapy equipment like chairs. For instance, in May 2018, Solihull Haematology and Oncology Day Unit project conducted by Solihull Hospital, managed by managed by University Hospitals Birmingham NHS Foundation, opened their new unit on chemotherapy treatment with an investment of US$ 2.5 million. They mentioned the requirement of 31 patient treatment chairs in the three years in which 24 chairs required in the initial stage. These kind of initiations in the treatment of cancers expected to increase the demand of chemotherapy chairs in the near future.
Global Chemotherapy Chairs Market - Regional Insights
North America is expected to hold a dominant position in the global chemotherapy chairs market during the forecast period, owing to increasing incidences of childhood cancer. For instance, according to the National Cancer Institute (NCI) report of 2018, it is estimated that around 15,590 children and adolescents aged 0 to 19 years were diagnosed with cancer and around 1,780 died of the disease in the U.S. in 2018.
Europe is expected to foresee a rapid growth in the global chemotherapy chairs market. The market in Europe is expected to gain momentum during the forecast period, owing to high presence of key players in the region such as Likamed GmbH, GREINER GmbH, and Bionic Medizintechnik GmbH. These are Germany-based companies, incorporated with advanced technology. Moreover, BMB Medical and Earthlite Medical are also Europe-based companies.
Global Chemotherapy Chairs Market Value (US$ Mn) & Y-o-Y Growth (%), 2016-2026
Source: Coherent Market Insights Analysis (2019)
Global Chemotherapy Chairs Market - Competitive Landscape
Key players operating in the global chemotherapy chairs market include BMB Medical, Earthlite Medical, Nanning Passion Medical Equipment, Likamed GmbH, GREINER GmbH, Bionic Medizintechnik GmbH, and Paramount Bed Co. Ltd.
Chemotherapy Chairs are extensively used for day care therapy as well outpatient clinic (OPD), of certain drugs to treat solid tumor cancers and hematological (blood) cancers through the systemic delivery of agents that have anti-tumor effects. Chemotherapy chairs are known for their comfort and used in hospitals, cancer care centers, and other specialty centers. The advancements in chemotherapy chairs is increasing the utilization especially in cancer care centres. Variability in length of treatment, increased chemotherapy chair demand, and maximized resource utilization is expected to drive the global chemotherapy chairs market during the forecast period.
Increasing prevalence of cancer worldwide is expected to boost global chemotherapy chairs market growth. According to National Cancer Institute (NCI), in 2016, an estimated 16.8 million new cases of cancer were diagnosed in the U.S., with around 595,690 deaths from the disease. Moreover, according to the same source, the number of people suffering from cancer is expected to reach to 19 million by 2024 in U.S. According to Cancer Atlas, 2012, around 1.1 million new cancer cases and 600,000 cancer deaths are reported annually in Latin America and the Caribbean, where lung cancer is the leading cause of cancer death for both sexes.
However, factors such as limited access to healthcare infrastructure, lack of technology, and lack of skilled healthcare professionals to guide through the chemotherapy procedure is expected to hinder the global chemotherapy chairs market. For instance, according to a study published in Lancet Journal in May 2019, between 2018 and 2040, the number of patients requiring first-course chemotherapy annually will increase to over 1.1 million from around 0.6 million in Africa. According to the same source, to deliver chemotherapy, 7,744 cancer specialists will be required in the next 22 years to treat nearly 200,000 new cancer cases in Africa. Moreover, in Somalia, with such limited healthcare and only 35 doctors per million citizens, patients struggle and very often die without medical care.
Key features of the study:
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
*Browse 35 market data tables and 27 figures on "Chemotherapy Chairs Market” - Global forecast to 2026”
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.